The trial is evaluating CMTX-101 as an adjunctive therapy to standard of care antibiotics in individuals with CF.

Independence Gold Corp. (TSXV: IGO) (OTCQB: IEGCF) ("Independence" or "the Company") is pleased to report the successful completion of its 2024-2025 drill program at the 3Ts Project. Located ...

Research out of South Korea reveals that when you exercise, your muscles release a powerful protein that acts like a biological time machine, potentially reversing age-related decline in both muscle ...

Roche and Prothena are advancing Prasinezumab to Phase 3 for Parkinson’s despite mixed Phase 2 results. Click here to read an ...

The Inflation Reduction Act includes an exemption for orphan drugs for a single indication, but experts say this is far from ...

Researchers found no significant benefit in short- or long-term mortality outcomes with pentoxifylline use. CHINA, June 26, 2025 /EINPresswire.com/ -- Severe alcohol-associated hepatitis (sAH) remains ...

In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant ...

As previously reported, 15 out of 16 (94%) patients in Phase 2b in the Per Protocol Population experienced Clinical Cure (CC) and all 15 of 15 (100%) ...

Research involving human participants must include adequate provisions to maintain the confidentiality of research data. Learn more about how the University of Nevada, Reno achieves this.